Baxter International Inc. BAX

Full chart Compare
Set alert

Price alert · BAX

All alert types
25.49 USD +1.27 (+5.22%)

At closeNov 3, 2026, 4:02 PM EST

25.56 +0.07 +0.29%

After hours · Nov 3, 4:02 PM ET

23.92 Day range 25.57
15.73 52-week range 30.00
YTD
+33.36%
1 year
+39.95%
Market cap
13.18B
Revenue (ttm)
11.61B
Profit margin
-6.23%
EPS (ttm)
-1.21
Shares out
517.35M
Forward P/E
12.48
Dividend
0.04 (0.17%)
Ex-dividend date
Aug 27, 2026
YTD return
+33.36%
1-year return
+39.95%
Volume
7.54M
Avg volume
6.59M
Open
24.04
Previous close
24.22
Day's range
23.92 – 25.57
52-week range
15.73 – 30.00
Beta
0.67
Analysts
Hold
Price target
27.08 (+6.3%)
Earnings date
Feb 11, 2027

YTD +5.68 (+29.13%)

152025Feb 3Apr 6Jun 4Aug 5Oct 525.18

Key statistics

Enterprise value
19.34B
PEG ratio
36.68
Price / sales
1.14
Price / book
2.03
Dividend yield
0.17%
Payout ratio
154.67%
Revenue growth
5.00%
Free cash flow
1.22B
Total cash
1.98B
Total debt
8.81B
Return on equity
-9.04%
Short % of float
7.24%
50-day average
24.54
200-day average
21.36

Financials — quick view

All financials
BAX Revenue — quarterly 2.98B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
BAX Net income — quarterly 294.00M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
BAX EPS — quarterly 0.57
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

BAX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 11, 2027Dec 30, 20260.60———
Oct 29, 2026Sep 30, 20260.5180.58+0.06+11.97%
Jul 30, 2026Jun 30, 20260.36650.56+0.19+52.80%
Apr 30, 2026Mar 31, 20260.3110.36+0.05+15.76%
Feb 12, 2026Dec 31, 20250.530.44-0.09-16.98%
Oct 30, 2025Sep 30, 20250.600.69+0.09+15.00%

Upgrades / downgrades

BAX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026JP MorganmainNeutralNeutral
Oct 30, 2026Wells FargomainEqual-WeightEqual-Weight
Oct 7, 2026Barclaysinit—Underweight
Oct 5, 2026CitigroupmainNeutralNeutral
Jul 31, 2026TD CowenmainHoldHold
Jul 31, 2026Wells FargomainEqual-WeightEqual-Weight

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
baxter.com

News

Your note

Sign in to keep a note on BAX — it syncs with the Stock Master app.

Insider holders

BAX insider holders
InsiderRelationLatest transactionDateShares held
BORZI JAMES WOfficerStock Award(Grant)Mar 5, 202573,134
GRADE JOEL T.Chief Financial OfficerStock Award(Grant)Feb 26, 2026279,828
HIDER ANDREW PChief Executive OfficerStock Award(Grant)Feb 26, 2026572,239
KNIGHT HEATHERChief Operating OfficerStock Award(Grant)Mar 5, 2025177,362
MASON JEANNE KOfficerStock Award(Grant)Mar 5, 2025199,659
RASUL REAZUROfficerStock Award(Grant)Feb 8, 2026139,846

Institution ownership

BAX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.82%81,842,1052.09BJun 29, 2026
Pzena Investment Management LLC12.07%62,425,6361.59BSep 29, 2026
Dodge & Cox Inc.11.29%58,386,3451.49BJun 29, 2026
FMR, LLC10.42%53,913,8311.37BJun 29, 2026
Vanguard Capital Management LLC6.52%33,754,280860.23MJun 29, 2026
Vanguard Portfolio Management LLC4.65%24,057,190613.10MJun 29, 2026

Fund ownership

BAX fund ownership
Holder% heldSharesValueReported
Dodge & Cox Funds-Dodge & Cox Stock Fund7.47%38,623,700984.33MJun 29, 2026
BLACKROCK EQUITY DIVIDEND FUND3.67%18,965,221483.33MJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%16,397,162417.88MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%13,382,913341.06MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.29%11,833,128301.57MJun 29, 2026
VANGUARD WINDSOR FUNDS-Vanguard Windsor Fund2.02%10,439,598266.05MJul 30, 2026